South Korea · Delayed Price · Currency is KRW Dong-A ST Company Description
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
It offers various ethical drugs, including Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Dulastin PFS and Leucostim injection/PFS to treat neutropenia in patients receiving myelosuppressive chemotherapy; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj.
to treat non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin inj./PFS for infertility and anovulation; Growtropin II inj./AQ /cartridge to treat growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Mainta inj.
for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel inj. to treat breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone tab.
for use in functional dyspepsia treatment; Stillen tab. to treat gastritis; Suganon tab./Sugamet XR tab.
for type 2 diabetes mellitus; Terizidone tab to treat active pulmonary and extra-pulmonary tuberculosis; and Zydena tab.
for erectile dysfunction treatment. The company also provides licensed-in and licensed-out drugs; and medical devices, which cover high-technology medical devices, custom-made products, and sets of artificial cardiac circuits for use in open-heart surgery.
Dong-A ST Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1932 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,679 |
| CEO | Jae-Hun Jung |
Contact Details
Address: 64 Cheonhodaero Seoul South Korea | |
| Phone | 82 2 920 8114 |
| Website | donga-st.com |
Stock Details
| Ticker Symbol | 170900 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7170900005 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jae-Hun Jung | Chief Executive Officer, President and Director |
| Jae-Hong Park | President and Director |
| GyuHong Jo | Managing Director |
| SunJong So | Managing Director |
| Yu-Seok Shin | Managing Director |
| SeongAe Yoon | Head |
| DaeWoo Lee | Executive Director |